IMMUNOASSAY FÜR COLLAGEN-TYP-VIII-SEQUENZEN

European patent · EP3337821 · In force

Register entry

Publication number
EP3337821
Application number
EP16756993
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 16, 2016
Published
Jun 27, 2018
Granted
Mar 18, 2020
Protection ends at the latest
Aug 15, 2036
Next annual fee due
Aug 31, 2027
IPC classes
C07K 16/18 (2006.01)
G01N 33/574 (2006.01)
G01N 33/68 (2006.01)
Priority
GB 201514658 18.08.2015
PCT application
PCT/EP2016/069453 16.08.2016
PCT publication
WO2017/029300 23.02.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. Mar 18, 2020

    Granted

    Published in Swissreg on 18.03.2020

Parties

Holder

Nordic Bioscience A/S

Herlev Hovedgade 207, 2730 Herlev, DK

Inventor

HANSEN, Niels, Ulrik, Brandt

2400 Copenhagen NV, DK

LEEMING, Diana, Julie, Oersnes

3060 Espergaerde, DK

KARSDAL, Morten, Asser

2100 København Ø, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.